Livagen

Livagen is a Hepatic & Immune Bioregulator supplied for laboratory research. Dual-action bioregulator studied in vitro for chromatin decondensation pathway modeling, liver function signaling research, and immune cell activation mechanism analysis.

Livagen (Lys-Glu-Asp-Ala) is a liver and immune peptide bioregulator studied for chromatin-decondensation and gene-activation signaling, with noted research interest in both hepatic and immune cells.

Livagen is a synthetic peptide rather than a tissue extract. Its sequence (Lys-Glu-Asp-Ala) is based on regulatory peptides linked to liver and immune tissue, and it is studied for chromatin-activation signaling.

Livagen is supplied as a lyophilized (freeze-dried) powder — a dehydrated form that keeps the peptide stable during shipping and storage. In the laboratory it is reconstituted (returned to liquid form) using a solvent such as bacteriostatic water, added slowly against the side of the vial, which is then swirled gently — never shaken — until the powder fully dissolves. All handling is for in vitro research use only.

Store the lyophilized Livagen powder at -20°C, protected from light and moisture, where it remains stable long-term. Once reconstituted, keep it refrigerated (2-8°C) and use it within the timeframe appropriate for your research protocol.

Every batch of Livagen is produced to a purity of 99% or higher. Purity and molecular identity are verified using standard analytical methods — high-performance liquid chromatography (HPLC) to measure purity, and mass spectrometry (MS) to confirm the peptide's molecular weight.